3188 results for «819»
3188 results
Redefining standards: TAVI in the era of lifetime management, beyond high-risk patients
29 Sep 2025 – From PCR Gulf Valves 2025
Discover a selection of cases showcasing the key features of the Navitor Valve System and its clinical applications. This session explores auxiliary access, the use of Navitor in alternative access and complex PCI, its performance in challenging peripheral anatomies, and innovative outcomes with the Vantage 30D...
Clinical cases
29 Sep 2025 – From PCR Gulf Valves 2025
This session presents challenging clinical cases focusing on post-TAVI paravalvular leakage and the percutaneous closure of paravalvular leaks following surgically implanted Intuity valves. Gain valuable insights into complex management strategies and procedural techniques addressing these complications.
Myval transcatheter heart valve series - Align for the future with novel design, data and daily clinical experience
29 Sep 2025 – From PCR Gulf Valves 2025
Join this comprehensive session to explore the Myval transcatheter heart valve series, featuring the latest clinical updates from two large randomized controlled trials—Landmark and Compare TAVI. Learn from real-world experiences, including recorded cases, and understand how these innovations translate to complex patient demographics in daily TAVI...
Mitral transcatheter edge-to-edge repair - LIVE Case
29 Sep 2025 – From PCR Gulf Valves 2025
A 65-year-old female with a history of atrial fibrillation, LAD PCI (2016), ICD implantation (2016), stroke, and insulin-dependent DM, presented with symptomatic severe secondary mitral regurgitation and poor left ventricular function (LVEF 20%). A single MitraClip was implanted under general anesthesia and TEE guidance.
LIVE Educational Case...
Tricuspid valve TEER workshop
29 Sep 2025 – From PCR Gulf Valves 2025
This workshop provides a comprehensive understanding of tricuspid valve anatomy, echocardiographic screening, and procedural guidance essential for successful tricuspid TEER. Learn to distinguish suitable candidates and gain hands-on experience with intra-procedural echocardiography techniques.
Vesalio announces FDA Approval of the NeVa VS™ to treat cerebral vasospasm after aneurysmal rupture
15 Sep 2022
Foldax announces positive one-year data on TRIA Mitral Valve
27 Jun 2025
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
